Publications - 'P'

Publications 376 - 400 de 2458
| % | ( | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | < | ? | A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | [ | ` | {
Titre DOI
PEDOT-PSS based 2-in-1 step-by-step films: A refined study
C. de Saint-Aubin; M.El Hajj Hassan; P. Kunemann; T. Patois; B. Lakard; R. Fabre; J. Hemmerle; P. Schaaf; M. Nardin; M.F. Vallat
2014
10.1016/j.synthmet.2014.04.003
Peer violence, mental health and suicidal ideation in a sample of French adolescent
C. Potard; V. Kubiszewski; R. Fontaine; R. Pochon; E. Rusch; R. Courtois
2014
10.1080/14623730.2014.963403
Peer-Reviewed Literature on Grain Legume Species in the WoS (1980-2018): A Comparative Analysis of Soybean and Pulses
M.B. Magrini; G. Cabanac; M. Lascialfari; G. Plumecocq; M.J. Amiot; M. Anton; G. Arvisenet; A. Baranger; L. Bedoussac; J.M. Chardigny; G. Duc; M.H. Jeuffroy; E.P. Journet; H. Juin; C. Larre; H. Leiser; V. Micard; D. Millot; M.L. Pilet-Nayel; C. Nguyen-The; T. Salord; A.S. Voisin; S. Walrand; J. Wery
2019
10.3390/su11236833
PEG Induces High Expression of the Cell Cycle Checkpoint Gene WEE1 in Embryogenic Callus of Medicago truncatula: Potential Link between Cell Cycle Checkpoint Regulation and Osmotic Stress
A.M. Elmaghrabi; H.J. Rogers; D. Francis; S.J. Ochatt
2017
10.3389/fpls.2017.01479
PELCZYNSKI SPACE IS ISOMORPHIC TO THE LIPSCHITZ FREE SPACE OVER A COMPACT SET
L.C. Garcia-Lirola; A. Prochazka
2019
10.1090/proc/14446
Peller's problem concerning Koplienko-Neidhardt trace formulae: the unitary case
C. Coine; C. Le Merdy; D. Potapov; F. Sukochev; A. Tomskova
2016
10.1016/j.jfa.2016.05.015
Pellets based on polyuronates: Relationship between gelation and release properties
U.T.D. Huynh; A. Assifaoui; O. Chambin
2017
10.1016/j.jfoodeng.2016.12.004
PELVIC CT CONTRIBUTIONS FOR EARLY DIAGNOSIS OF INFECTIOUS SACRO ILIITIS
M. Sondag; K. Gete; F. Verhoeven; S. Aubry; C. Prati; D. Wendling
2019
10.1136/annrheumdis-2019-eular.6641
Pembrolizumab (pembro) vs placebo as adjuvant therapy for patients (pts) with renal cell carcinoma (RCC): Patient-reported outcomes (PRO) in KEYNOTE-564
T.K. Choueiri; P. Tomczak; S.H. Park; B. Venugopal; S. Symeonides; J. Hajek; T. Ferguson; Y.H. Chang; J.L. Lee; N. Haas; P. Sawrycki; N. Sarwar; M. Gross-Goupil; A. Thiery-Vuillemin; M. Mahave; T.L. Saretsky; P. Zhang; J. Willemann-Rogerio; D.I. Quinn; T.B. Powles
2021
10.1016/j.annonc.2021.08.049
Pembrolizumab alone or in combination with chemotherapy as first-line therapy for patients with advanced gastric or gastroesophageal junction adenocarcinoma: results from the phase II nonrandomized KEYNOTE-059 study
Y.J. Bang; Y.K. Kang; D.V. Catenacci; K. Muro; C.S. Fuchs; R. Geva; H. Hara; T. Golan; M. Garrido; S.I. Jalal; C. Borg; T. Doi; H.H. Yoon; M.J. Savage; J. Wang; R.P. Dalal; S. Shah; Z.A. Wainberg; H.Cheol Chung
2019
10.1007/s10120-018-00909-5
Pembrolizumab as first-line therapy in microsatellite instability metastatic colorectal cancers
D. Pureur; M. Rodrigues; A. Turpin
2021
10.1016/j.bulcan.2021.01.004
PEMBROLIZUMAB IN COMBINATION WITH XELOX BEVACIZUMAB IN PATIENTS WITH MICROSATELLITE STABLE (MSS) METASTATIC COLORECTAL CANCER AND A HIGH IMMUNE INFILTRATE: A PROOF OF CONCEPT STUDY. FFCD 1703 POCHI
D. Tougeron; J.Francois Emile; S. Kim; C. Monterymard; M. Gilabert; B. Jeremie; A. Lievre; L. Dahan; P. Laurent-Puig; L. Mineur; R. Coriat; J.Louis Legoux; V. Hautefeuille; J.Marc Phelip; T. Lecomte; H. Sokol; C. Capron; C. Gallois; V. Randrian; C. Lepage; J. Taieb
2020
10.1136/jitc-2020-SITC2020.0337
Pembrolizumab monotherapy for the adjuvant treatment of renal cell carcinoma post-nephrectomy: Randomized, double-blind, Phase III KEYNOTE-564 study
T.K. Choueiri; D.I. Quinn; T. Zhang; H. Gurney; G.K. Doshi; P.Wayne Cobb; F. Parnis; J.L. Lee; S.Hoon Park; A. Semenov; A. Thiery-Vuillemin; P. Sawrycki; P. Tomczak; B. Alekseev; A. Izmailov; W.YenHwa Chang; S.M. Wan; C.Heinrich Poehlein; J. Willemann-Rogerio; T. Powles
2019
10.1158/1538-7445.AM2019-CT162
Pembrolizumab versus placebo as post-nephrectomy adjuvant therapy for patients with renal cell carcinoma: Randomized, double-blind, phase III KEYNOTE-564 study.
T.K. Choueiri; P. Tomczak; S.Hoon Park; B. Venugopal; T. Ferguson; Y.H. Chang; J. Hajek; S.N. Symeonides; J.L. Lee; N. Sarwar; A. Thiery-Vuillemin; M. Gross-Goupil; M. Mahave; N.B. Haas; P. Sawrycki; E.(Pingye) Zhang; J.Willemann Rogerio; K. Imai; D.I. Quinn; T. Powles
2021
10.1200/JCO.2021.39.15_suppl.LBA5
Pembrolizumab with Capox Bevacizumab in patients with microsatellite stable metastatic colorectal cancer and a high immune infiltrate: The FFCD 1703-POCHI trial
C. Gallois; J.F. Emile; S. Kim; C. Monterymard; M. Gilabert; J. Bez; A. Lievre; L. Dahan; P. Laurent-Puig; L. Mineur; R. Coriat; J.L. Legoux; V. Hautefeuille; J.M. Phelip; T. Lecomte; H. Sokol; C. Capron; V. Randrian; C. Lepage; N. Lomenie; C. Kurtz; J. Taieb; D. Tougeron
2021
10.1016/j.dld.2021.06.009
PEMFC stack voltage singularity measurement and fault classification
D. Benouioua; D. Candusso; F. Harel; L. Oukhellou
2014
10.1016/j.ijhydene.2014.09.117
Penetration of Daptomycin into Bone and Synovial Fluid in Joint Replacement
D. Montange; F. Berthier; G. Leclerc; A. Serre; L. Jeunet; M. Berard; P. Muret; L. Vettoretti; J. Leroy; B. Hoen; C. Chirouze
2014
10.1128/AAC.02344-14
PEOPLE WITH INSULIN-TREATED DIABETES HAVE ACHIEVED AN ORIGINAL EDUCATIONAL PROGRAM FOR THE USE OF FLASH GLUCOSE MONITORING: RESULTS FROM A COHORT OF 814 SUBJECTS
B. Rudoni; D. Capelle; A. Demongeot; M.C. Brindisi; B. Verges; J.M. Petit
2020
PEOPLE WITH INSULIN-TREATED DIABETES HAVE ACHIEVED AN ORIGINAL EDUCATIONAL PROGRAM FOR THE USE OF FLASH GLUCOSE MONITORING: RESULTS FROM A COHORT OF 814 SUBJECTS
B. Rudoni; D. Capelle; A. Demongeot; M.C. Brindisi; B. Verges; J.M. Petit
2020
People with type 1 diabetes and psychosis have a markedly increased risk of hospitalisation for acute diabetes complications
J. Petit; K. Goueslard; J. Cottenet; J.C. Chauvet-Gelinier; B. Bouillet; B. Verges; C. Quantin
2017
People with type 1 diabetes and psychosis have a markedly increased risk of hospitalisation for acute diabetes complications
J. Petit; K. Goueslard; J. Cottenet; J.C. Chauvet-Gelinier; B. Bouillet; B. Verges; C. Quantin
2017
PEPCOL: a GERCOR randomized phase II study of nanoliposomal irinotecan PEP02 (MM-398) or irinotecan with leucovorin/5-fluorouracil as second-line therapy in metastatic colorectal cancer
B. Chibaudel; F. Maindrault-Goebel; J.B. Bachet; C. Louvet; A. Khalil; O. Dupuis; P. Hammel; M.L. Garcia; M. Bennamoun; D. Brusquant; C. Tournigand; T. Andre; C. Arbaud; A.K. Larsen; Y.W. Wang; G. Yeh; F. Bonnetain; A. de Gramont
2016
10.1002/cam4.635
PEPCOL: A randomized noncomparative phase II study of PEP02 (MM-398) or irinotecan in combination with leucovorin and 5-fluorouracil as second-line therapy in patients with unresectable metastatic colorectal cancer-A GERCOR Study.
B. Chibaudel; F. Maindrault-Goebel; T. Andre; J.Baptiste Bachet; C. Louvet; A. Khalil; O.Jean Marie Dupuis; P. Hammel; M.Line Garcia; M. Bennamoun; D. Brusquant; C. Arbaud; Y.W. Wang; G. Yeh; F. Bonnetain; A. de Gramont; GERCOR
2015
10.1200/jco.2015.33.3_suppl.751
Peptidoglycan-dependent NF-kappa B activation in a small subset of brain octopaminergic neurons controls female oviposition
A. Masuzzo; G. Maniere; A. Viallat-Lieutaud; E. Avazeri; O. Zugasti; Y. Grosjean; L. Kurz; J. Royet
2019
10.7554/eLife.50559
Perceived comfort and values of travel time savings in the Rhone-Alpes Region
H. Bouscasse; M. de Lapparent
2019
10.1016/j.tra.2019.04.006

Pages